Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Minoxidil helps hair regrowth in alopecia areata safely.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Ruxolitinib can help regrow hair in severe alopecia areata.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.